Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Stock
Equities
688621
CNE100005139
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55.85 CNY | -4.45% | -0.89% | -19.93% |
Sales 2024 * | 1.26B 174M | Sales 2025 * | 1.65B 229M | Capitalization | 6.26B 866M |
---|---|---|---|---|---|
Net income 2024 * | 277M 38.34M | Net income 2025 * | 388M 53.71M | EV / Sales 2024 * | 4.97 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
22.5
x | P/E ratio 2025 * |
14.1
x | Employees | 1,126 |
Yield 2024 * |
1.24% | Yield 2025 * |
1.63% | Free-Float | 52.15% |
1 day | -4.45% | ||
1 week | -0.89% | ||
Current month | -0.89% | ||
1 month | -10.97% | ||
3 months | -15.63% | ||
6 months | -22.06% | ||
Current year | -19.93% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Jing Liu
CEO | Chief Executive Officer | 42 | 09-02-28 |
Ling Yang Zhao
DFI | Director of Finance/CFO | 36 | 20-03-20 |
Ming Juan Wang
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Qian Li
CHM | Chairman | 43 | 09-03-08 |
Qiao Chen
BRD | Director/Board Member | 44 | 20-03-20 |
Zhuang Kun He
BRD | Director/Board Member | 52 | 20-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 55.85 | -4.45% | 1,641,703 |
24-05-09 | 58.45 | +1.26% | 1,568,796 |
24-05-08 | 57.72 | -1.05% | 1,373,555 |
24-05-07 | 58.33 | -1.03% | 1,423,705 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.93% | 866M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- 688621 Stock